Are peptides legal in Georgia?

Can a Georgia resident get peptides by telehealth?

Georgia Composite Medical Board rule 360-3-.07 (Practice through electronic or other such means) authorizes telemedicine by a Georgia-licensed physician, physician assistant, or advanced practice registered nurse when the provider has personally seen and examined the patient and provides ongoing care electronically, is covering for or acting at the request of a Georgia-licensed clinician who examined the patient, or can examine the patient using technology or peripherals equal or superior to an in-person exam. Board rule 360-3-.02(6) separately makes it unprofessional conduct to provide treatment by electronic means unless a history and physical examination of the patient has been performed by a Georgia licensee, with exceptions for on-call coverage and consultations. In its January 10, 2024 statement the Board said an in-person visit is not required for every prescription, but that its rules in general require a patient to be examined once in person before an initial prescription for controlled substances and/or dangerous drugs, and that telemedicine providers must make diligent efforts to have patients examined in person annually. Under O.C.G.A. 16-13-71 a dangerous drug is any non-scheduled drug that federal law allows to be dispensed only by prescription, which includes GLP-1 drugs. In December 2023 the Board announced it would end its COVID-era tele-prescribing flexibility, and after an extension through May 1, 2024 licensees must follow the Medical Practice Act and Board rules strictly. A questionnaire-only first prescription does not meet this standard. Out-of-state providers need a Georgia license. On scope: neither rule 360-3-.07 (unchanged since September 28, 2020 in the Administrative Code current through September 2, 2026) nor rule 360-3-.02 draws a line between controlled and non-controlled dangerous drugs, so the same exam requirement applies to a first GLP-1 prescription; the only alternative to a prior in-person exam or a referral from an examining Georgia clinician is an exam using technology or peripherals equal or superior to an in-person exam under rule 360-3-.07(a)(3)(d). [2] [3] [4] [7] [8] [9]

How does the Georgia pharmacy board treat compounding?

The Georgia State Board of Pharmacy regulates pharmacies under O.C.G.A. Title 26, Chapter 4 and Board rules in chapter 480 of the Rules and Regulations of the State of Georgia. Georgia has no separate state bulks list; Board rule 480-11-.02(6) lets pharmacists compound from bulk substances that meet an applicable USP-NF monograph, are components of FDA-approved drugs, or are otherwise approved by FDA, and federal 503A limits apply on top of that. Since July 1, 2013, O.C.G.A. 26-4-114.1 requires any person, pharmacy, or facility outside Georgia that ships, mails, or delivers dispensed drugs into Georgia to hold a Georgia nonresident pharmacy permit; under Board rule 480-6-.02 the pharmacist in charge must be licensed in the pharmacy's home state, and a nonresident pharmacy that performs sterile or non-sterile compounding must submit an inspection report with its application. Compounding standards are in Board rule chapter 480-11 (Pharmaceutical Compounding): rule 480-11-.02(8) makes all sterile compounded preparations subject to USP chapter 797 and non-sterile preparations subject to USP chapter 795, rule 480-11-.02(12)(b) bars compounding essentially copies of commercially available products except for a prescriber-ordered change for an individual patient, unavailability, or a drug-shortage listing, rule 480-11-.04(3) sets the facility and equipment requirements for sterile parenteral compounding, and rule 480-11-.09 requires a quality assurance program for sterile preparations. [1] [5] [6] [10] [12]

Can you get compounded GLP-1s in Georgia?

The practical Georgia barrier is the prescription itself: many national asynchronous GLP-1 programs must add a video exam or require a prior in-person exam for Georgia patients to satisfy rule 360-3-.07. [3] [4] [15]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Georgia?

Find a provider in Georgia

• Compounding pharmacies in Georgia
• Clinics in Georgia
• Telehealth providers in Georgia

Is it legal to buy research peptides in Georgia?

Only Georgia-licensed pharmacies and permitted nonresident pharmacies may dispense prescription drugs to Georgia patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling and are not dispensed by a pharmacist. Georgia law also bars the sale directly: O.C.G.A. 26-3-10 provides that no person shall sell, deliver, offer for sale, hold for sale, or give away any new drug unless an application for it has become effective under section 505 of the federal act (or, for a drug not subject to the federal act, a state application has been filed with the State Board of Pharmacy), with an exemption only for drugs intended solely for investigational use by qualified experts and plainly labeled "For investigational use only." [5] [11] [16]

Peptide-specific notes for Georgia

Compare: Semaglutide vs tirzepatide.

Frequently asked questions

From the blog

• Can you get a GLP-1 through telehealth in your state?

  Yes in every state, but the rules for the visit, the prescriber's license, and the pharmacy differ. How state telehealth law shapes GLP-1 access, with ten state examples.

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.